Cargando…

Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial

BACKGROUND: Diabetes mellitus, as well as subsequent ocular complications such as cystoid macular edema (CME), are of fundametal socio-economic relevance. Therefore, we evaluated the influence of internal limiting membrane (ILM) removal on longterm morphological and functional outcome in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoerauf, Hans, Brüggemann, Anne, Muecke, Manuela, Lüke, Julia, Müller, Maya, Stefánsson, Einar, Hammes, Hans-Peter, Weiß, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124640/ https://www.ncbi.nlm.nih.gov/pubmed/21243370 http://dx.doi.org/10.1007/s00417-010-1610-8

Ejemplares similares

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy
por: Yamakiri, Keita, et al.
Publicado: (2008)

Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge system
por: dell’Omo, Roberto, et al.
Publicado: (2012)

Ciliary body length revisited by anterior segment optical coherence tomography: implications for safe access to the pars plana for intravitreal injections
por: Lincke, Joel-Benjamin, et al.
Publicado: (2020)

Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole
por: Fujikawa, Masato, et al.
Publicado: (2013)

Vitrectomy and scleral imbrication in patients with myopic traction maculopathy and macular hole retinal detachment
por: Ando, Yoshimasa, et al.
Publicado: (2016)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
por: Ruiz-Moreno, José M., et al.
Publicado: (2022)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema
por: Fujino, Ryosuke, et al.
Publicado: (2020)

Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021)

Influence of pars plana vitrectomy for macular surgery on the medium term intraocular pressure
por: Lauermann, Peer, et al.
Publicado: (2020)

Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
por: de Salles, Manuel Casselholm, et al.
Publicado: (2021)

Changes of retinal oxygen saturation during treatment of diabetic macular edema with a pre-defined regimen of aflibercept: a prospective study
por: Hasan, Somar M., et al.
Publicado: (2021)

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016)

Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
por: Li, Xiaoxin, et al.
Publicado: (2017)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT
por: Gu, Sophie Z., et al.
Publicado: (2022)

See clearer: survey on the subjective and objective information levels as well as perception and information transfer using virtual reality headsets in patients with diabetic macular edema receiving anti-VEGF treatment
por: Enders, Christian, et al.
Publicado: (2022)

Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study
por: Deuchler, Svenja K., et al.
Publicado: (2022)

Vitrectomy with and without encircling band for pseudophakic retinal detachment with inferior breaks: VIPER Study Report No. 3
por: Baumgarten, Sabine, et al.
Publicado: (2018)

Choroidal thickness in lamellar macular holes
por: Kal, Magdalena, et al.
Publicado: (2020)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema
por: Ulrich, Jan Niklas
Publicado: (2017)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Fixation behavior in macular dystrophy assessed by microperimetry
por: Chiang, Wei-Yu, et al.
Publicado: (2018)

A retrospective, multicenter study on the management of macular holes without residual internal limiting membrane: the refractory macular hole (ReMaHo) study
por: Lorenzi, Umberto, et al.
Publicado: (2022)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
por: Wong, Yun, et al.
Publicado: (2016)

Inflammation and Macular Oedema after Pars Plana Vitrectomy
por: Romano, Vito, et al.
Publicado: (2013)

Secondary Macular Holes Post Pars Plana Vitrectomy
por: Okonkwo, Ogugua N, et al.
Publicado: (2022)

Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion
por: Francone, Anibal, et al.
Publicado: (2021)

Effects of cataract surgery in Japanese patients with neovascular age-related macular degeneration
por: Nishiguchi, Fumi, et al.
Publicado: (2020)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema
por: Dehghan, Mohammad-Hossein, et al.
Publicado: (2010)

Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
por: Dubey, Arvind Kumar, et al.
Publicado: (2016)

Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
por: Flikier, Stephanie, et al.
Publicado: (2019)

Pars plana vitrectomy for tractional diabetic macular edema with or without internal limiting membrane peeling
por: Khattab, Abdelrahman Ahmed Ali, et al.
Publicado: (2022)

Risk Factors of Cystoid Macular Edema After Pars Plana Vitrectomy for Pseudophakic Retinal Detachment
por: Bernabei, Federico, et al.
Publicado: (2023)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration
por: Cozzi, Mariano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jv34bikl9fk0a76ic5f7583a92